11 assets in Venous Thromboembolism

Therapeutic assets addressing Venous Thromboembolism, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Apixaban Venous Thromboembolism	Regeneron Pharmaceuticals	P4	BBB (79)
Aspirin Venous Thromboembolism	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P4	BBB (76)
Rivaroxaban Venous Thromboembolism	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P3	BBB (74)
Dalteparin Venous Thromboembolism	Beijing Friendship Hospital	P4	BBB (73)
Dipyridamole Venous Thromboembolism	Northern Jiangsu People's Hospital	P4	BB (71)
Tinzaparin Venous Thromboembolism	University College Dublin	P3	BB (64)
Enoxaparin Venous Thromboembolism	University College Dublin	P3	B (62)
Atezolizumab Venous Thromboembolism	Jia Fan	P3	B (60)
Cenvacibart Venous Thromboembolism	Regeneron Pharmaceuticals	P3	B (60)
Kinisoquin™ Venous Thromboembolism	Quercis Pharma AG	P3	B (60)
Shr-2004 Venous Thromboembolism	Beijing Suncadia Pharmaceuticals Co., Ltd	P2	B (57)